Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 StudiesKai En Chan, Mark Muthiah, Elden Yen Hng Ong et al.|Clinical Gastroenterology and Hepatology|2023Cited by 126
Low liver fat in non‐alcoholic steatohepatitis‐related significant fibrosis and cirrhosis is associated with <scp>hepatocellular carcinoma</scp>, decompensation and mortalitySung Won Lee, Rohit Loomba, Daniel Q. Huang et al.|Alimentary Pharmacology & Therapeutics|2023Cited by 24
Quantitative measurements of M2BPGi depend on liver fibrosis and inflammationHaruki Uojima, Masashi Mizokami, Miyako Murakawa et al.|Journal of Gastroenterology|2024Cited by 23
Serum Growth Differentiation Factor 15 Can Be a Novel Biomarker to Predict the Prognosis of Patients With Hepatitis C Virus Cirrhosis After Virus EliminationYuta Myojin, Tetsuo Takehara, Hayato Hikita et al.|Hepatology Research|2025Cited by 3